Sector revisions AstraZeneca PLC

Equities

Market Closed - London S.E. Other stock markets 16:35:05 13/05/2026 BST			5-day change	1st Jan Change
13,766.00 ^GBX	+0.13%		+1.47%	-0.17%

02:51pm	ASTRAZENECA : Jefferies remains its Buy rating	ZD
01:12pm	AstraZeneca, Owkin to Develop AI Agents for Drug Discovery Decision-making	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ASTRAZENECA PLC							21
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							17
	NOVARTIS AG							21
	MERCK & CO., INC.							27
	NOVO NORDISK A/S							23
	AMGEN INC.							30
	GILEAD SCIENCES, INC.							28
	PFIZER INC.							27
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							28
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	BAYER AG							19
	Average							23
	Weighted average by Cap.							25